🟡Watchlist WEDNESDAY December 18,2024… in progress
NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
$KULR Technology (KULR.US)$ PR 12/17: Signs Service Agreement to Launch KULR ONE Space Battery. COH $13.4M good for 9 months
$Wearable Devices (WLDS.US)$ PR 12/17: Wearable Devices and RayNeo Unveil First Neural-Controlled AR Glasses at CES 2025, Serving as the Catalyst for Strategic Collaborations and OEM Integrations. Low float. SI 13.28%, CTB 295%. COH $5.1M good for 8 months.
$Tenaya Therapeutics (TNYA.US)$ PR 12/17: encouraging early data from the first cohort of patients in the MyPEAK-1 clinical trial of TN-201 gene therapy for hypertrophic cardiomyopathy. Beaten today, may recover tomorrow. SI 25.47%. COH $129.6M good for 16.2 months. Large float
$Biomea Fusion (BMEA.US)$ PR 12/17: Covalent III study met primary endpoints for Diabetes Mellitus Type 2. Didn’t get traction today. SI 44.16%. COH $62M good for 6.2 months
$Actuate Therapeutics (ACTU.US)$ PR 12/17: Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer. Statistically significant and met primary endpoints. Didn’t get traction today. Low float. COH $8.5M good for 4.5 months
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
$KULR Technology (KULR.US)$ PR 12/17: Signs Service Agreement to Launch KULR ONE Space Battery. COH $13.4M good for 9 months
$Wearable Devices (WLDS.US)$ PR 12/17: Wearable Devices and RayNeo Unveil First Neural-Controlled AR Glasses at CES 2025, Serving as the Catalyst for Strategic Collaborations and OEM Integrations. Low float. SI 13.28%, CTB 295%. COH $5.1M good for 8 months.
$Tenaya Therapeutics (TNYA.US)$ PR 12/17: encouraging early data from the first cohort of patients in the MyPEAK-1 clinical trial of TN-201 gene therapy for hypertrophic cardiomyopathy. Beaten today, may recover tomorrow. SI 25.47%. COH $129.6M good for 16.2 months. Large float
$Biomea Fusion (BMEA.US)$ PR 12/17: Covalent III study met primary endpoints for Diabetes Mellitus Type 2. Didn’t get traction today. SI 44.16%. COH $62M good for 6.2 months
$Actuate Therapeutics (ACTU.US)$ PR 12/17: Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer. Statistically significant and met primary endpoints. Didn’t get traction today. Low float. COH $8.5M good for 4.5 months
$Forward Industries (FORD.US)$ 2 PRs 12/17: (1) Partners with The Digital Medicine Society (DiMe) Initiative to Advance Digitally-Enabled Hospital-at-Home Care; and (2) Expands Partnership with Intelligent Product Solutions and Commercializes NeuStim™ Technology for Stroke and Spinal Cord Injury. Microfloat. COH $2.5M
$Corvus Pharmaceuticals (CRVS.US)$ : Scheduled TOMORROW to announce interim Phase 1 data evaluating drug for moderate to severe atopic dermatitis. COH $51.9M goodsfor 27.5 months
$Nouveau Monde Graphite (NMG.US)$ PR 12/17: Announces US$50-Million Equity Investment from Canada Growth Fund and the Government of Québec to Support its Phase 2 Ore-to-Battery-Material Graphite Operations. COH $25.6M good for 10.9 months
$Lipocine (LPCN.US)$ PR 12/17: FDA Fast track designation for patients with sarcopenia secondary to decompensated liver cirrhosis. Low float. COH $19M good for 58.7 months
$Vast Renewables (VSTE.US)$ PR 12/17: 13D 64.2%. Low float. CTB 287%. COH. No cash! HIGH risk for dilution. You are warned.
$Corvus Pharmaceuticals (CRVS.US)$ : Scheduled TOMORROW to announce interim Phase 1 data evaluating drug for moderate to severe atopic dermatitis. COH $51.9M goodsfor 27.5 months
$Nouveau Monde Graphite (NMG.US)$ PR 12/17: Announces US$50-Million Equity Investment from Canada Growth Fund and the Government of Québec to Support its Phase 2 Ore-to-Battery-Material Graphite Operations. COH $25.6M good for 10.9 months
$Lipocine (LPCN.US)$ PR 12/17: FDA Fast track designation for patients with sarcopenia secondary to decompensated liver cirrhosis. Low float. COH $19M good for 58.7 months
$Vast Renewables (VSTE.US)$ PR 12/17: 13D 64.2%. Low float. CTB 287%. COH. No cash! HIGH risk for dilution. You are warned.
$Sintx Technologies (SINT.US)$ PR 12/17: Patent For Silicon Nitride Laser Cladding, Enabling Superior Bioactive Coatings On Medical Implants. Low float. 0 shares LTB. CTB 273%. COH $2.6M good for 3.1 months
$SaverOne 2014 (SVRE.US)$ Pr 12/17: Expands Global Reach With UK Distribution Agreement With Smartfits To Provide Driver Distraction Prevention Technology For Fleet Safety Across Key Industries. Low float. No cash. HIGH risk for dilution.
$Rockwell Medical (RMTI.US)$ PR 12/17: Enters Into a Multi-Year Product Purchase Agreement With the World's Leading Provider of Dialysis Products and Services. COH $1.1M
$Joby Aviation (JOBY.US)$ PR 12/17: Completes First FAA Testing on Major Aircraft Aerostructure. SI 16%. No dilution risk.
$Tonix Pharmaceuticals (TNXP.US)$ PR 12/17: FDA accepted NDA for treatment of fibromyalgia. Rallied for 2 days, beaten by shorts minutes after approval. Recovering after hours. May continue recovering tomorrow. COH $19.6 months good for 3.8 months.
$SaverOne 2014 (SVRE.US)$ Pr 12/17: Expands Global Reach With UK Distribution Agreement With Smartfits To Provide Driver Distraction Prevention Technology For Fleet Safety Across Key Industries. Low float. No cash. HIGH risk for dilution.
$Rockwell Medical (RMTI.US)$ PR 12/17: Enters Into a Multi-Year Product Purchase Agreement With the World's Leading Provider of Dialysis Products and Services. COH $1.1M
$Joby Aviation (JOBY.US)$ PR 12/17: Completes First FAA Testing on Major Aircraft Aerostructure. SI 16%. No dilution risk.
$Tonix Pharmaceuticals (TNXP.US)$ PR 12/17: FDA accepted NDA for treatment of fibromyalgia. Rallied for 2 days, beaten by shorts minutes after approval. Recovering after hours. May continue recovering tomorrow. COH $19.6 months good for 3.8 months.
$Nukkleus (NUKK.US)$ PR 12/17: Nukkleus successfully acquired a 51% controlling stake in Star 26 Capital Inc., a defense acquisition company. Acquisition is valued at $26M. Ran hard today. Still strong after hours. May continue tomorrow. 0 shares LTB. COH $1.4M good for 4.9 months. High risk for dilution.
$Asset Entities (ASST.US)$ No PR. Up after hours with good volume. Probable upcoming PR or pure momentum play. May continue. COH $2.8M good for 7.4 months
$1847 Holdings (EFSH.US)$ PR AH 12/17: Completes Acquisition of Leading Cabinetry, Millwork & Door Manufacturer which is expected to add $33.1 Million in Revenue and $10.4 Million in Net Income. Low float China stock. COH $29.3M good for 27.9 months
$1847 Holdings (EFSH.US)$ PR AH 12/17: Completes Acquisition of Leading Cabinetry, Millwork & Door Manufacturer which is expected to add $33.1 Million in Revenue and $10.4 Million in Net Income. Low float China stock. COH $29.3M good for 27.9 months
$Transocean (RIG.US)$ PR AH 12/17: Secures $111M Ultra-Deepwater Drillship Contract For Dhirubhai Deepwater KG1 With Reliance Industries Limited In India. SI 21%. No risk for dilution
$Richtech Robotics (RR.US)$ No PR but ER expected after market close. Previous EPS was loss of 0.02 and revenue of $1.17M. COH $27.6
$Quantum Computing (QUBT.US)$ PR 12/17: Awarded Contract by NASA to Support Phase Unwrapping Using Dirac-3 Photonic Optimization Solve. Up after hours. SI 15.74%. COH $86.1M good for 62.2 months
$CERo Therapeutics (CERO.US)$ PR AH: 13G COH $3.5M good for 4.8 months
$ParaZero Technologies (PRZO.US)$ PR 12/16: Regains compliance. Up after hours. May continue but if ever, will just be in PM unless there is upcoming PR. CTB 202%. COH $3.4M good for 10.2 months
$CERo Therapeutics (CERO.US)$ PR AH: 13G COH $3.5M good for 4.8 months
$ParaZero Technologies (PRZO.US)$ PR 12/16: Regains compliance. Up after hours. May continue but if ever, will just be in PM unless there is upcoming PR. CTB 202%. COH $3.4M good for 10.2 months
$MSP Recovery (MSPR.US)$ PR AH 12/17: 13D 54.9% & 47.8%. Low float.0 shares LTB, CTB 190%. COH No cash! High risk for dilution
$The Glimpse (VRAR.US)$ No PR. Up after hours. May continue. Low float. COH $1.2M good for 7 months.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
3905Followers
73Following
43KVisitors
Follow
72473894 : Gratitude.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
151158967 : Legend
72281059 : No matter how much news comes out, it's useless if it doesn't go up again.
Bunny R : Thank you for sharing
Lnova :
what happen to Tenaya today why down 50% ![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
. I was interested in their news I was thinking of getting a call option. I have calls for KULR I hope it runs more
Lnova : **also just my experience with $SaverOne 2014 (SVRE.US)$ if anyone is new to this stock, the share price does not always behave logically. I think it is heavily shorted. Several times it’s had great news and the price does not reflect it. I don’t know why the price stays low/falls - just something to be aware of. I just add my experience cause I have lost money on $SaverOne 2014 (SVRE.US)$ before when I had expected it to run and it didn’t. Just be cautious there. I do believe it will become a valuable stock eventually- the company has made a software product that can get utilized in government contracts and even save lives. I just don’t know what is going on with the share price. I don’t think it’s a reflection of the value of the company, or their software… I think the stock price just gets manipulated / shorted
wait7 : Thank you Thank you
sirstu1 : you're doing gods work
Lnova : $Quantum Computing (QUBT.US)$ has cash on hand for 5 years? That’s good
104659513 : thank you for your hard work always.